256 related articles for article (PubMed ID: 16995478)
21. Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus.
Zingg U; Montani M; Frey DM; Dirnhofer S; Esterman AJ; Went P; Oertli D
Eur J Surg Oncol; 2010 Jul; 36(7):670-7. PubMed ID: 20510571
[TBL] [Abstract][Full Text] [Related]
22. Chemoimmunotherapy of murine mammary adenocarcinomas.
Ames IH
Anticancer Res; 2004; 24(4):2249-56. PubMed ID: 15330169
[TBL] [Abstract][Full Text] [Related]
23. Influence of neoadjuvant radio-chemotherapy on tumor-infiltrating lymphocytes in squamous esophageal cancer.
Zingg U; Montani M; Frey DM; Dirnhofer S; Went P; Oertli D
Eur J Surg Oncol; 2009 Dec; 35(12):1268-72. PubMed ID: 19632080
[TBL] [Abstract][Full Text] [Related]
24. Effect of preoperative short course famotidine on TILs and survival in breast cancer.
Parshad R; Hazrah P; Kumar S; Gupta SD; Ray R; Bal S
Indian J Cancer; 2005; 42(4):185-90. PubMed ID: 16391436
[TBL] [Abstract][Full Text] [Related]
25. Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
Yamaguchi Y; Satoh Y; Miyahara E; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
Anticancer Res; 1995; 15(5B):2201-6. PubMed ID: 8572625
[TBL] [Abstract][Full Text] [Related]
26. Systemic and local immunosuppression in pancreatic cancer patients.
von Bernstorff W; Voss M; Freichel S; Schmid A; Vogel I; Jöhnk C; Henne-Bruns D; Kremer B; Kalthoff H
Clin Cancer Res; 2001 Mar; 7(3 Suppl):925s-932s. PubMed ID: 11300493
[TBL] [Abstract][Full Text] [Related]
27. Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy.
Recchia F; Saggio G; Cesta A; Alesse E; Gallo R; Necozione S; Rea S
Anticancer Res; 2005; 25(4):3149-57. PubMed ID: 16080579
[TBL] [Abstract][Full Text] [Related]
28. Immune effects of preoperative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose interleukin-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients.
Lissoni P; Brivio F; Brivio O; Fumagalli L; Gramazio F; Rossi M; Emanuelli G; Alderi G; Lavorato F
J Biol Regul Homeost Agents; 1995; 9(1):31-3. PubMed ID: 8553906
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-18 and -12 synergistically enhance cytotoxic functions of tumor-infiltrating lymphocytes.
Chen ZF; Zhou R; Xia B; Deng CS
Chin Med J (Engl); 2012 Dec; 125(23):4245-8. PubMed ID: 23217394
[TBL] [Abstract][Full Text] [Related]
30. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
31. Tumor-associated macrophage (TAM) infiltration in gastric cancer.
Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Okumura H; Matsumoto M; Miyazono F; Hokita S; Aikou T
Anticancer Res; 2003; 23(5A):4079-83. PubMed ID: 14666722
[TBL] [Abstract][Full Text] [Related]
32. Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma.
Anraku M; Cunningham KS; Yun Z; Tsao MS; Zhang L; Keshavjee S; Johnston MR; de Perrot M
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):823-9. PubMed ID: 18374762
[TBL] [Abstract][Full Text] [Related]
33. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
[TBL] [Abstract][Full Text] [Related]
34. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
[TBL] [Abstract][Full Text] [Related]
35. Clinical and biological effects of interleukin-2 with or without a concomitant administration of granulocyte-macrophage colony-stimulating factor in metastatic cancer patients.
Lissoni P; Mengo S; Bucovec R; Brivio F; Fumagalli L; Tancini G; Gardani GS
In Vivo; 2003; 17(1):73-5. PubMed ID: 12655794
[TBL] [Abstract][Full Text] [Related]
36. Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study.
Strong VE; Devaud N; Allen PJ; Gonen M; Brennan MF; Coit D
Ann Surg Oncol; 2009 Jun; 16(6):1507-13. PubMed ID: 19347407
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-2 based immunotherapy in patients with metastatic renal cell carcinoma.
Donskov F
Dan Med Bull; 2007 Nov; 54(4):249-65. PubMed ID: 18208677
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma.
Chen CH; Lee HS; Huang GT; Yang PM; Yu WY; Cheng KC; Lee PH; Jeng YM; Chen DS; Sheu JC
Hepatogastroenterology; 2007; 54(77):1529-33. PubMed ID: 17708291
[TBL] [Abstract][Full Text] [Related]
39. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.
Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A
Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327
[TBL] [Abstract][Full Text] [Related]
40. Pre-operative interleukin-2 immunotherapy induces eosinophilic infiltration in colorectal neoplastic stroma.
Bovo G; Brivio F; Brenna A; Fumagalli L; Perego P; Brivio O; Uggeri F; Lavorato F; Bratina G
Pathologica; 1995 Apr; 87(2):135-8. PubMed ID: 8532404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]